Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Aldose reductase inhibitors from Dainippon

Sep. 27, 1996

Antihyperglycemic agents from Wyeth-Ayerst

Sep. 27, 1996

Takeda's pipeline of metabolic drugs

Sep. 27, 1996

Orphan drug finally approved for urea cycle disorders

Sep. 27, 1996

Tularik-Japan Tobacco leptin gene collaboration

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Hypocholesterolemic and hypocholesterolemic/antioxidant compounds from Pierre Fabre

Sep. 27, 1996

Takeda reports new agent for improving lipid metabolism

Sep. 27, 1996

Nippon Shoji's newest ACAT inhibitors

Sep. 27, 1996

Kyowa Hakko describes protein inducing osteoblast proliferation

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...